These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 225005)

  • 21. Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma.
    Kushitani K; Takeshima Y; Amatya VJ; Furonaka O; Sakatani A; Inai K
    Pathol Int; 2007 Apr; 57(4):190-9. PubMed ID: 17316414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistological staining of reactive mesothelium, mesothelioma, and lung carcinoma with a panel of monoclonal antibodies.
    Ghosh AK; Gatter KC; Dunnill MS; Mason DY
    J Clin Pathol; 1987 Jan; 40(1):19-25. PubMed ID: 2434531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility and pitfalls of immunohistochemistry in the differential diagnosis between epithelioid mesothelioma and poorly differentiated lung squamous cell carcinoma.
    Kushitani K; Amatya VJ; Okada Y; Katayama Y; Mawas AS; Miyata Y; Okada M; Inai K; Kishimoto T; Takeshima Y
    Histopathology; 2017 Feb; 70(3):375-384. PubMed ID: 27589012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistological study of malignant diffuse mesotheliomas of the pleura.
    Loosli H; Hurlimann J
    Histopathology; 1984 Sep; 8(5):793-803. PubMed ID: 6083969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in lectin binding of malignant pleural mesothelioma and adenocarcinoma of the lung.
    Kawai T; Greenberg SD; Truong LD; Mattioli CA; Klima M; Titus JL
    Am J Pathol; 1988 Feb; 130(2):401-10. PubMed ID: 2449084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A comparison of the sialyl SSEA-1 antigen and CEA in the histology of malignant mesothelioma, with special reference to adenocarcinoma of the lung].
    Kishimoto T; Okada K; Shimamoto F; Sato T; Ono T
    Gan No Rinsho; 1988 Nov; 34(14):1951-5. PubMed ID: 2462647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [CEA in lung cancer: CEA immunohistochemical study of 150 cases].
    Yao YZ
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Jun; 13(3):133-5, 189. PubMed ID: 2174305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prognostic value of serum and tissue CEA evaluation in lung cancer].
    Leonardo E; Navone R; Dogliotti C; Oliaro A
    Minerva Med; 1985 Nov; 76(44):2111-6. PubMed ID: 4069423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of thrombomodulin immunostaining in the diagnosis of mesothelioma.
    Ordóñez NG
    Histopathology; 1997 Jul; 31(1):25-30. PubMed ID: 9253621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonal antibodies against mesothelial membrane antigen discriminate between malignant mesothelioma and lung adenocarcinoma.
    Stahel RA; O'Hara CJ; Waibel R; Martin A
    Int J Cancer; 1988 Feb; 41(2):218-23. PubMed ID: 3276635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies.
    Abutaily AS; Addis BJ; Roche WR
    J Clin Pathol; 2002 Sep; 55(9):662-8. PubMed ID: 12194995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenocarcinoma of the lung. Immunohistochemical findings (keratin/CEA).
    Brockmann M; Brockmann I; Herberg U; Müller KM
    J Cancer Res Clin Oncol; 1987; 113(4):379-82. PubMed ID: 2439516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant mesotheliomas. Improved differential diagnosis from lung adenocarcinomas using monoclonal antibodies 44-3A6 and 624A12.
    Lee I; Radosevich JA; Chejfec G; Ma YX; Warren WH; Rosen ST; Gould VE
    Am J Pathol; 1986 Jun; 123(3):497-507. PubMed ID: 3717302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesothelioma: profile of keratin proteins and carcinoembryonic antigen: an immunoperoxidase study of 20 cases and comparison with pulmonary adenocarcinomas.
    Corson JM; Pinkus GS
    Am J Pathol; 1982 Jul; 108(1):80-8. PubMed ID: 6178295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of tumour markers in malignant mesothelioma and pulmonary adenocarcinoma.
    Gibbs AR; Harach R; Wagner JC; Jasani B
    Thorax; 1985 Feb; 40(2):91-5. PubMed ID: 2579450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carcinoembryonic antigen in effusions. A diagnostic adjunct to cytology.
    Pinto MM; Bernstein LH; Brogan DA; Criscuolo EM
    Acta Cytol; 1987; 31(2):113-8. PubMed ID: 3548190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical study of carcinoembryonic antigen (CEA) in lung carcinoma by five monoclonal antibodies.
    Hiraoka K; Horie A
    J UOEH; 1988 Sep; 10(3):237-46. PubMed ID: 2845551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cytodiagnosis of lung diseases].
    Atay Z; Grenze H; Schagen A
    Med Klin; 1970 Nov; 65(48):2097-100. PubMed ID: 4321990
    [No Abstract]   [Full Text] [Related]  

  • 39. [Carcinoembryonic antigen in pleural effusion. Adenocarcinoma versus mesothelioma].
    Supervía A; Guitart AC; Rubio J; Cornudella R
    Rev Clin Esp; 1992 Feb; 190(2):69-71. PubMed ID: 1561440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The utility of B72.3, carcinoembryonic antigen, and Leu M-1 in cell blocks: an adjunct to fine-needle aspiration diagnosis of bronchioloalveolar carcinoma of the lung.
    Chandan VS; Truong LD; Khurana KK
    Cancer; 2005 Aug; 105(4):246-52. PubMed ID: 15971208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.